| pubmed-article:19202447 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19202447 | lifeskim:mentions | umls-concept:C0348050 | lld:lifeskim |
| pubmed-article:19202447 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:19202447 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
| pubmed-article:19202447 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
| pubmed-article:19202447 | lifeskim:mentions | umls-concept:C2757068 | lld:lifeskim |
| pubmed-article:19202447 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:19202447 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:19202447 | lifeskim:mentions | umls-concept:C0205280 | lld:lifeskim |
| pubmed-article:19202447 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19202447 | pubmed:dateCreated | 2009-2-9 | lld:pubmed |
| pubmed-article:19202447 | pubmed:abstractText | Few prospective trials in human leukocyte antigen (HLA) identical living donor (LD) renal transplantation exist. This prospective study evaluated a corticosteroid (CS)-free, calcineurin inhibitor (CNI) minimization immunosuppressive regimen in HLA-identical LD renal transplant recipients. | lld:pubmed |
| pubmed-article:19202447 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19202447 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19202447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19202447 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19202447 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19202447 | pubmed:issn | 1534-6080 | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:FirstM RoyMR | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:WoodleE... | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:AllowayRita... | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:Roy-Chaudhury... | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:WeimertNicole... | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:CardiMichael... | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:MogilishettyG... | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:WalkerJennife... | lld:pubmed |
| pubmed-article:19202447 | pubmed:author | pubmed-author:RikeAdele HAH | lld:pubmed |
| pubmed-article:19202447 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19202447 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:19202447 | pubmed:volume | 87 | lld:pubmed |
| pubmed-article:19202447 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19202447 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19202447 | pubmed:pagination | 408-14 | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:meshHeading | pubmed-meshheading:19202447... | lld:pubmed |
| pubmed-article:19202447 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19202447 | pubmed:articleTitle | A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation. | lld:pubmed |
| pubmed-article:19202447 | pubmed:affiliation | Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH 45267-0585, USA. | lld:pubmed |
| pubmed-article:19202447 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19202447 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
